These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 6535265

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Changes in prevalence, intensity of infection and morbidity due to Schistosoma japonicum infection in a community following a single treatment with praziquantel.
    Zhao G, Jiang Q, Wasley A, Zhang S, ljWu Z, Liu Z, Yuan H.
    Trop Geogr Med; 1995; 47(6):289-92. PubMed ID: 8650742
    [Abstract] [Full Text] [Related]

  • 28. [Compliance analysis of the residents with mass medical treatment in areas highly endemic for schistosomiasis].
    Guo JG, Hu GH, Xiong YL.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(1):58-9. PubMed ID: 12567481
    [No Abstract] [Full Text] [Related]

  • 29. Further experience with praziquantel in schistosoma japonicum infections.
    Fu FY, Zheng JS, Chen WQ, Qin KS, Jin MY, Liu X, Wang QL, Lu SC.
    Chin Med J (Engl); 1984 Jan; 97(1):47-52. PubMed ID: 6428832
    [No Abstract] [Full Text] [Related]

  • 30. Clinical experience with praziquantel in the treatment of Nigerian patients infected with S. haematobium.
    Oyediran AB, Kofie BA, Bammeke AO, Bamgboye EA.
    Arzneimittelforschung; 1981 Jan; 31(3a):581-4. PubMed ID: 7016124
    [Abstract] [Full Text] [Related]

  • 31. [Praziquantel in the treatment of schistosomiasis].
    Nahmias J, Aziz E, Geraci L.
    Harefuah; 1983 Oct 16; 105(8):214-5. PubMed ID: 6681381
    [No Abstract] [Full Text] [Related]

  • 32. [The value of praziquantel in treating schistosomiasis complicated by cardiac diseases (author's transl)].
    Shen GR.
    Zhonghua Yi Xue Za Zhi; 1982 Mar 16; 62(3):163-4. PubMed ID: 6809260
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Double-blind clinical trial comparing praziquantel with oxamniquine in schistosomiasis mansoni.
    Katz N, Rocha RS.
    Rev Inst Med Trop Sao Paulo; 1982 Mar 16; 24(5):310-4. PubMed ID: 6762634
    [No Abstract] [Full Text] [Related]

  • 38. [Drug therapy of mansoni schistosomiasis].
    Zeitune JM, Ramos SR, Sugmyama LC, Côrte AA.
    Arq Gastroenterol; 1980 Mar 16; 17(2):88-95. PubMed ID: 7213141
    [Abstract] [Full Text] [Related]

  • 39. [Epidemiological study of foci of S. intercalatum schistosomiasis in Eseka and Edea (Cameroon). Effects of treatment with praziquantel].
    Ripert C, Carrié J, Pagbe JJ, Ravinet L, Deniau M, Same Ekobo A.
    Arzneimittelforschung; 1981 Mar 16; 31(3a):584-9. PubMed ID: 7195250
    [Abstract] [Full Text] [Related]

  • 40. Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience.
    Chen MG.
    Acta Trop; 2005 Mar 16; 96(2-3):168-76. PubMed ID: 16125657
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.